Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 studyResearch in context

Summary: Background: Rosai-Dorfman disease (RDD) is a rare heterogeneous histiocytic disorder lacking standardized first-line treatment. Methods: This single-center, phase 2 prospective study enrolled 13 newly diagnosed and 10 recurrent RDD patients from June 2021 to March 2023 at Peking Union Medi...

Descrición completa

Detalles Bibliográficos

Principais autores:	Long Chang, Min Lang, Ting Liu, He Lin, Zheng-Zheng Liu, Hao Cai, Dao-bin Zhou, Xin-xin Cao
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2024-07-01
Series:	EClinicalMedicine
Assuntos:	Rosai-Dorfman disease Treatment Lenalidomide Dexamethasone
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2589537024002645
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!